Management of diabetic cats with long-acting insulin

Vet Clin North Am Small Anim Pract. 2013 Mar;43(2):251-66. doi: 10.1016/j.cvsm.2012.12.005.

Abstract

This article provides an overview of the most important information regarding the long-acting insulins glargine, detemir, and protamine zinc insulin in diabetic cats. Dosing protocols are described in detail, which achieve high remission rates and optimal glycemic control. Complications and factors that typically cause insulin resistance are also examined.

Publication types

  • Review

MeSH terms

  • Animals
  • Cat Diseases / drug therapy*
  • Cats
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / veterinary*
  • Diabetic Ketoacidosis / chemically induced
  • Diabetic Ketoacidosis / prevention & control
  • Diabetic Ketoacidosis / veterinary
  • Dose-Response Relationship, Drug
  • Hypoglycemia / chemically induced
  • Hypoglycemia / prevention & control
  • Hypoglycemia / veterinary
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance
  • Insulin, Long-Acting / adverse effects
  • Insulin, Long-Acting / therapeutic use*
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting